{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:09:29Z","timestamp":1791565769599,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ejps.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T00:46:07Z","timestamp":1340066767000},"page":"387-393","source":"Crossref","is-referenced-by-count":9,"title":["Glucosamine and adjuvant arthritis: A pharmacokinetic and pharmacodynamic study"],"prefix":"10.1016","volume":"47","author":[{"given":"Mohammad H.","family":"Gilzad-Kohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhreddin","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.06.003_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005344-198811020-00013","article-title":"Verapamil pharmacodynamics and disposition in obese hypertensive patients","volume":"11","author":"Abernethy","year":"1988","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0010","first-page":"149s","article-title":"Dose escalation study of glucosamine to treat adjuvant arthritis in the rat","volume":"14","author":"Agahzadeh-Habashi","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.18433\/J3XG6F","article-title":"The glucosamine controversy; a pharmacokinetic issue","volume":"14","author":"Aghazadeh-Habashi","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0020","first-page":"181","article-title":"Single dose pharmacokinetics and bioavailability of glucosamine in the rat","volume":"5","author":"Aghazadeh-Habashi","year":"2002","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.abb.2011.03.014","article-title":"Oral glucosamine increases expression of transforming growth factor beta1 (TGFbeta1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity","volume":"510","author":"Ali","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejps.2012.06.003_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","article-title":"Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy","volume":"43","author":"Anderson","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2012.06.003_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vph.2006.06.009","article-title":"Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease\u2013drug interaction between inflammation, pravastatin, and propranolol","volume":"46","author":"Clements","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.18433\/J3D012","article-title":"Norepinephrine transporter is involved in down-regulation of beta1-adrenergic receptors caused by adjuvant arthritis","volume":"12","author":"Clements","year":"2009","journal-title":"J. Pharm. Pharm. Sci.: Publ. Canadian Soc. Pharm. Sci., Soc. Canadienne Sci. Pharm."},{"key":"10.1016\/j.ejps.2012.06.003_b0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1592\/phco.2005.25.9.1213","article-title":"Protective effects of angiotensin II interruption: evidence for antiinflammatory actions","volume":"25","author":"Dagenais","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2012.06.003_b0050","first-page":"332","article-title":"COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter","volume":"7","author":"Davies","year":"2004","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/A:1011928732588","article-title":"Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats","volume":"15","author":"Emami","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2012.06.003_b0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4067\/S0716-97602004000400015","article-title":"Regulation of cardiac excitation\u2013contraction coupling by sorcin, a novel modulator of ryanodine receptors","volume":"37","author":"Farrell","year":"2004","journal-title":"Biol. Res."},{"key":"10.1016\/j.ejps.2012.06.003_b0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0961203305lu2199oa","article-title":"Cardiovascular involvement in rheumatoid arthritis","volume":"14","author":"Gerli","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.ejps.2012.06.003_b0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0076-6879(96)68026-4","article-title":"Quantitation of nitrate and nitrite in extracellular fluids","volume":"268","author":"Grisham","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejps.2012.06.003_b0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.bjp.0707538","article-title":"Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers","volume":"153","author":"Hanafy","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00467-008-1064-y","article-title":"Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease","volume":"24","author":"Hanafy","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2012.06.003_b0085","article-title":"Inflammation alters angiotensin converting enzymes (ACE and ACE-2) balance in rat heart","author":"Hanafy","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.ejps.2012.06.003_b0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","article-title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Harirforoosh","year":"2009","journal-title":"Expert Opin. Drug. Saf."},{"key":"10.1016\/j.ejps.2012.06.003_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00011-004-1333-6","article-title":"Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats","volume":"54","author":"Hua","year":"2005","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejps.2012.06.003_b0100","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/glia.21058","article-title":"Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia\/reperfusion injury","volume":"58","author":"Hwang","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.ejps.2012.06.003_b0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.18433\/J3T01S","article-title":"Improved sensitive high performance liquid chromatography assay for glucosamine in human and rat biological samples with fluorescence detection","volume":"13","author":"Ibrahim","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0110","doi-asserted-by":"crossref","DOI":"10.3109\/03009742.2011.573503","article-title":"Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s","author":"Kapetanovic","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejps.2012.06.003_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2011.02526.x","article-title":"Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","author":"Kim","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejps.2012.06.003_b0120","first-page":"602","article-title":"Drug disease interactions: role of inflammatory mediators in disease and variability in drug response","volume":"8","author":"Kulmatycki","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0091270008328099","article-title":"Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab","volume":"49","author":"Ling","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2125.2000.00314.x","article-title":"Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis","volume":"50","author":"Mayo","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0090-9556(25)08410-7","article-title":"Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. role of protein binding","volume":"24","author":"Mehvar","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.06.003_b0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics","volume":"85","author":"Morgan","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.06.003_b0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1063-4584(05)80007-X","article-title":"Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee","volume":"2","author":"Muller-Fassbender","year":"1994","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ejps.2012.06.003_b0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.lfs.2010.02.015","article-title":"Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model","volume":"86","author":"Naito","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0155","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.10499","article-title":"Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits","volume":"46","author":"Oegema","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejps.2012.06.003_b0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0090-9556(25)06525-0","article-title":"Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis","volume":"23","author":"Piquette-Miller","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.06.003_b0165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/0003-4819-148-4-200802190-00005","article-title":"Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial","volume":"148","author":"Rozendaal","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2012.06.003_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2011.04019.x","article-title":"Drug\u2013disease interaction: Crohn\u2019s disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity","author":"Sanaee","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0175","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bjp.0705202","article-title":"Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart","volume":"139","author":"Sattari","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2012.06.003_b0180","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/ard.2009.120469","article-title":"Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT","volume":"69","author":"Sawitzke","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2012.06.003_b0185","first-page":"538","article-title":"Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat","volume":"3","author":"Setnikar","year":"1984","journal-title":"Pharmatherapeutica"},{"key":"10.1016\/j.ejps.2012.06.003_b0190","first-page":"1109","article-title":"Pharmacokinetics of glucosamine in man","volume":"43","author":"Setnikar","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2012.06.003_b0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-4347(92)80101-U","article-title":"Simultaneous direct determination of the enantiomers of verapamil and norverapamil in plasma using a derivatized amylose high-performance liquid chromatographic chiral stationary phase","volume":"574","author":"Shibukawa","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejps.2012.06.003_b0200","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/art.20951","article-title":"Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis","volume":"52","author":"Tiraloche","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejps.2012.06.003_b0205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-3495(90)82392-4","article-title":"Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum","volume":"58","author":"Valdivia","year":"1990","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2012.06.003_b0210","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ejps.2007.05.070","article-title":"Experience of the dispensing of plant and sea animal extract-based rheumatoid arthritis drugs","volume":"32","author":"Vrublevska","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.06.003_b0215","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/art.22574","article-title":"The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis","volume":"56","author":"Wang","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejps.2012.06.003_b0220","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.joca.2010.05.012","article-title":"Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes","volume":"18","author":"Wen","year":"2010","journal-title":"Osteoarthritis Cartilage"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T22:44:53Z","timestamp":1743547493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0928098712002473"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.06.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}